According to the report, the global hydrocephalus market generated $6.90 billion in 2020, and is expected to reach $10.17 billion by 2030, witnessing a CAGR of 4.0% from 2021 to 2030. Hydrocephalus is mostly caused due to an injury that affects the brain nerves, and cerebrospinal fluids. The increase in the prevalence of neurological disorders, such as brain tumors, spinal cord injury, and stroke, are more prone to develop hydrocephalus and drive the growth of the market.
Key Market Aspects:
Market Size and Growth:
According to the report, the global hydrocephalus industry generated $6.90 billion in 2020, and is expected to reach $10.17 billion by 2030, indicating a slightly slower but still robust growth rate.
Geographic Distribution:
The market is segmented geographically into North America, Europe, Asia-Pacific, and the Rest of the World. America is currently the leading region in the hydrocephalus market.
Get Sample Report at: https://www.alliedmarketresearch.com/request-sample/15360
Hydrocephalus Market Segmentation
Based on cause, the acquired hydrocephalus segment contributed to the highest share in 2020, accounting for more than half of the global hydrocephalus market, and is projected to continue its dominance during the forecast period. This is due to increase in neurological disorders and injuries such as intraventricular hemorrhage, stroke, tumor, and several other types of CSF infections that can result in the development of hydrocephalic conditions among patients. However, the congenital hydrocephalus segment is projected to witness the largest CAGR of 4.3% from 2021 to 2030.
Based on age, the adults segment accounted for the largest share in 2020, holding more than half of the global hydrocephalus market, and is expected to continue its leadership status during the forecast period. Moreover, this segment is projected to register the highest CAGR of 4.3% from 2021 to 2030. This is due to rise in the incidences of intraventricular hemorrhage or other brain injuries. The report also analyzes the neonate and pediatrics segment.
Based on region, North America held the highest market share in 2020, accounting for more than two-fifths of the global hydrocephalus market, and is expected to continue its lead in terms of revenue by 2030. This is due to rise in prevalence of the neurological disorder, increase in the number of hydrocephalus patients, development of advanced healthcare medical devices, and advancements in technology for hydrocephalus in the region. However, Asia-Pacific is expected to manifest the fastest CAGR of 5.0% during the forecast period. This is due to rise in awareness regarding minimally invasive surgeries, surge in cases of stroke and CSF related disorders, and technological advancements.
Leading Market Players
- Aesculap Inc.
- Integra Lifesciences
- Karl Storz Se And Co. Kg
- Proteses Inc.
- Medtronic Plc.
- Natus Medical Inc.
- Boston Children’s Hospital
- Anadolu Medical Center
- Helios Hospital
- Texas Children’s Hospital
- Children’s National Hospital
Key Benefits for Stakeholders
- This report provides a quantitative analysis of the market segments, current trends, estimations, and dynamics of the market analysis from 2021 to 2031 to identify the prevailing market Opportunity.
- The market research is offered along with information related to key drivers, restraints, and opportunities.
- Porter’s five forces analysis highlights the potency of buyers and suppliers to enable stakeholders make profit-oriented business decisions and strengthen their supplier-buyer network.
- In-depth analysis of the market segmentation assists to determine the prevailing market opportunities.
- Major countries in each region are mapped according to their revenue contribution to the global market.
- Market player positioning facilitates benchmarking and provides a clear understanding of the present position of the market players.
- The report includes the analysis of the regional as well as global trends, key players, market segments, application areas, and market growth strategies.
Read More:
Operating Room Management Market Worth USD 10.0 billion by 2031 at a CAGR of 13.0%
Hemodialysis Market to Reach US$ 111.8 Billion in 2032, Says Allied Market Research
Contact Details:
David Correa
USA/Canada (Toll Free): +1-800-792-5285, +1-503-894-6022
About Us
Allied Market Research (AMR) is a full-service market research and business-consulting wing of Allied Analytics LLP based in Portland, Oregon. Allied Market Research provides global enterprises as well as medium and small businesses with unmatched quality of “Market Research Reports” and “Business Intelligence Solutions.” AMR has a targeted view to provide business insights and consulting to assist its clients to make strategic business decisions and achieve sustainable growth in their respective market domain.




